Selected article for: "biomarker development and drug development"
Author: Weinrich, Dirk; Jonkheijm, Pascal; Niemeyer, Christof M.; Waldmann, Herbert
Title: Applications of Protein Biochips in Biomedical and Biotechnological Research
  • Cord-id: gubekyum
  • Document date: 2009_9_15
    • ID: gubekyum
    Snippet: Progress in the development of protein‐immobilization strategies and methods has made protein biochips increasingly accessible. The integration of these assay and analysis platforms into biomedical and biotechnological research has substantially expanded the repertoire of methods available for proteomics and biomarker research and for drug development. This Minireview highlights selected developments in the application of protein biochips in these fields.
    Document: Progress in the development of protein‐immobilization strategies and methods has made protein biochips increasingly accessible. The integration of these assay and analysis platforms into biomedical and biotechnological research has substantially expanded the repertoire of methods available for proteomics and biomarker research and for drug development. This Minireview highlights selected developments in the application of protein biochips in these fields.

    Search related documents:
    Co phrase search for related documents
    • absence presence and additional information: 1, 2, 3
    • absence presence and long period: 1, 2, 3, 4, 5
    • absence presence and low abundance: 1, 2
    • absence presence and low sample consumption: 1
    • active enzyme and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity base and acute respiratory syndrome: 1, 2
    • activity base and long term monitoring: 1
    • activity profiling and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and additional information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long term monitoring: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute respiratory syndrome and low abundance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and low sample consumption: 1, 2